Follow The Filings

VIR Vir Biotechnology

Vir Biotechnology earnings company data as of 8:13 PM ET 11/17

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS -0.73 -0.57 Beat
Rev $1.2M — —

Insider trades

Open-market buys and sales by VIR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All VIR insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $7M sold by 6 insiders under 10b5-1 plans
  1. Vanina De Verneuil EVP, General Counsel, Corp Sec
    Planned sale
    $27K 2,407 shares at $11.10 2.1% of stake
    Traded Nov 3 Filed Nov 4
  2. Janet Napolitano Director
    Planned sale
    $30K 3,200 shares at $9.45 13% of stake
    Traded Jun 1 Filed Jun 2
  3. Brent Sabatini SVP, Chief Accounting Officer
    Planned sale
    $3,582 379 shares at $9.45 0.6% of stake
    Traded Jun 1 Filed Jun 2
  4. Vicki L. Sato Director
    Planned sale
    $221K 22,000 shares at $10.05 2% of stake
    Traded May 1 Filed May 4
  5. Vicki L. Sato Director
    Planned sale
    $200K 22,000 shares at $9.07 2% of stake
    Traded Apr 1 Filed Apr 2
  6. Brent Sabatini SVP, Chief Accounting Officer
    Planned sale
    $70K 7,711 shares at $9.12 11% of stake
    Traded Mar 23 Filed Mar 24
  7. Vicki L. Sato Director
    Planned sale
    $209K 22,000 shares at $9.51 1.9% of stake
    Traded Mar 2 Filed Mar 3
  8. Vicki L. Sato Director
    Planned sale
    $413K 42,377 shares at $9.75 3.6% of stake
    Traded Feb 24 Filed Feb 26
  9. Mark Eisner EVP and Chief Medical Officer
    Planned sale
    $19K 1,889 shares at $9.82 1.2% of stake
    Traded Feb 25 Filed Feb 26
  10. Vanina De Verneuil EVP, General Counsel, Corp Sec
    Planned sale
    $135K 13,700 shares at $9.82 11% of stake
    Traded Feb 25 Filed Feb 26
  11. Vicki L. Sato Director
    Planned sale
    $170K 22,000 shares at $7.71 1.9% of stake
    Traded Feb 2 Filed Feb 3
  12. Vicki L. Sato Director
    Planned sale
    $130K 22,000 shares at $5.93 1.9% of stake
    Traded Jan 2 Filed Jan 5
  13. SVF Endurance (Cayman) Ltd 10% owner, +2 joint filers
    Planned sale
    $1.1M 191,854 shares at $5.98 1.4% of stake
    Traded Dec 1, 2025 Filed Dec 3, 2025
  14. Vicki L. Sato Director
    Planned sale
    $132K 22,000 shares at $6.00 1.8% of stake
    Traded Dec 1, 2025 Filed Dec 2, 2025
  15. SVF Endurance (Cayman) Ltd 10% owner, +2 joint filers
    Planned sale
    $1.2M 189,431 shares at $6.41 1.3% of stake
    Traded Nov 26–28 Filed Dec 1, 2025

Also filed in the last 12 months, not counted as buying or selling: 17 stock grants, 13 sales to cover taxes, 6 other transactions, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 24 shown.

Filed Form Detail Links
424B5
424B5
8-K 1.01,8.01,9.01
424B5
SCHEDULE 13G —
8-K 7.01,8.01,9.01
SCHEDULE 13D/A —
10-Q
8-K 2.02,9.01
8-K 5.02
SCHEDULE 13G/A —
8-K 3.02,8.01,9.01
8-K 8.01,9.01
8-K 5.02,7.01,9.01
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
SCHEDULE 13G/A —
8-K 5.02
8-K 5.02
8-K 5.02,5.07
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf